Skip to content

Mesoblast

US · MESO #2849 by market cap Listed 2015
13.94 +0.33 +2.42%
Live - 5344 symbols - heartbeat 283s ago · 2026-10-08 07:49
Pre-market 13.70 -1.72%
After-hours 13.90 -0.29%
Overnight 13.48 -3.30%
Market cap
1.81B
P/B
3.19
EPS
-0.44
Reader sentiment Are you bullish or bearish on MESO?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $11
    Market Newswire · 2024/10/31
  • Rating change
    Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $18
    Market Newswire · 2024/11/6
  • Rating change
    Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $30
    Market Newswire · 2025/9/6
  • Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $35
    Market Newswire · 2026/4/10
  • Rating change
    Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $35
    Market Newswire · 2025/10/9
  • Rating change
    Piper Sandler Upgrades Mesoblast(MESO.US) to Buy Rating
    Market Newswire · 2024/7/24
  • Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $39
    Market Newswire · 2026/8/27
  • Rating change
    Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $15
    Market Newswire · 2024/12/21
  • Rating change
    Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Announces Target Price $11
    Market Newswire · 2024/8/29
  • Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $35
    Market Newswire · 2026/3/2
  • Mesoblast (MESO.US) will release its earnings report after the market close on August 26.
    Market Newswire · 2026/8/24
  • Rating change
    Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $24
    Market Newswire · 2025/2/7
  • Rating change
    Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $30
    Market Newswire · 2024/12/21
  • Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $35
    Market Newswire · 2026/9/26
  • Rating change
    Maxim Group Upgrades Mesoblast(MESO.US) to Buy Rating, Cuts Target Price to $12
    Market Newswire · 2024/9/24
  • Rating change
    Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $24
    Market Newswire · 2025/9/10

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:49:29 · For reference only, not investment advice and not tailored to your situation.